Should be an interesting few weeks coming up. The phase 1 Progenza trial is coming up to completion, John Martin has stated results of this trial will be released in May. A positive result should lead to a significant re-rate. I suspect, in addition, it may trigger another milestone payment from AGC.
Ann: Appendix 3Y Change of Director's Interest Notice, page-8
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CMB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.772M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1267251 | 0.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 746300 | 6 |
View Market Depth
| Last trade - 16.12pm 03/07/2024 (20 minute delay) ? |
| CMB (ASX) Chart |
Day chart unavailable